BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
11.39
-0.85 (-6.94%)
At close: Dec 5, 2025, 4:00 PM EST
11.83
+0.44 (3.85%)
After-hours: Dec 5, 2025, 7:03 PM EST
BriaCell Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
| Net Income | -26.31 | -4.79 | -20.3 | -26.84 | -13.82 | |
| Depreciation & Amortization | 0.11 | 0.08 | 0.02 | 0.02 | 0.02 | |
| Loss (Gain) on Equity Investments | 0.22 | 0.11 | - | - | - | |
| Stock-Based Compensation | 0.78 | 1.8 | 2.19 | 3.07 | 1.97 | |
| Other Operating Activities | -1.06 | -28.38 | -2.12 | 11.66 | 6.36 | |
| Change in Accounts Receivable | 0.73 | -0.73 | 0.01 | -0.01 | 0.01 | |
| Change in Accounts Payable | -3.89 | 6.05 | 0.66 | 0.25 | -1.41 | |
| Change in Other Net Operating Assets | 1.25 | 1.74 | -4.2 | -0.63 | -0.89 | |
| Operating Cash Flow | -28.17 | -24.13 | -23.74 | -12.48 | -7.75 | |
| Capital Expenditures | - | -0.46 | - | - | - | |
| Investment in Securities | -7.65 | -0.23 | - | - | - | |
| Investing Cash Flow | -7.65 | -0.68 | - | - | - | |
| Short-Term Debt Issued | - | - | - | - | 0.22 | |
| Total Debt Issued | - | - | - | - | 0.22 | |
| Short-Term Debt Repaid | - | - | - | - | -0.55 | |
| Total Debt Repaid | - | - | - | - | -0.55 | |
| Net Debt Issued (Repaid) | - | - | - | - | -0.33 | |
| Issuance of Common Stock | 45.45 | 4.42 | 4 | 6.51 | 65.33 | |
| Repurchase of Common Stock | - | - | -0.05 | -10.17 | - | |
| Other Financing Activities | - | - | - | -0.08 | - | |
| Financing Cash Flow | 45.45 | 4.42 | 3.95 | -3.74 | 65 | |
| Net Cash Flow | 9.63 | -20.39 | -19.79 | -16.23 | 57.25 | |
| Free Cash Flow | -28.17 | -24.58 | -23.74 | -12.48 | -7.75 | |
| Free Cash Flow Per Share | -66.58 | -224.09 | -228.03 | -120.86 | -257.22 | |
| Levered Free Cash Flow | -18.89 | -10.83 | -15.87 | -6.86 | -5.83 | |
| Unlevered Free Cash Flow | -18.87 | -10.83 | -15.87 | -6.86 | -5.78 | |
| Change in Working Capital | -1.91 | 7.05 | -3.53 | -0.39 | -2.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.